Lv12
58 积分 2026-07-01 加入
NSCLC: Five trials to watch
9天前
已完结
Cancer burden and control in China: landscape, trends and challenges
20天前
已完结
Assessment of delays in diagnosis of lung cancer in interstitial lung disease
1个月前
已完结
Compound EGFR mutations are predominantly PACC (P-loop and alpha-C helix compressing) mutations with increased responsiveness to second- vs third-generation tyrosine kinase inhibitors
1个月前
已完结
皖公网安备34019202002308
